drugs that act as direct agonists or antagonists at NT receptors
benztropine
ropinerole
SGAs (second generation antipsychotics)
decrease dopamine activity by blocking D2 dopamine receptors
first generation antipsychotics (FGAs)
sinemet
what drugs increase NT production
sinemet
what drugs act by blocking NT degradation
enhance cholinergic effects by inhibiting acetylcholinesterase (AChE)
cholinesterase inhibitors (ChEIs)
cholinesterase inhibitors used in the tx of alzheimer’s disease; increases cholinergic activity in the hippocampus and cerebral cortex
donezipil, galantimine, rivastigmine
cholinesterase inhibitor used in the tx of myasthenia gravis; increases cholinergic activity at NMJ
pyridostigmine
MAOI used either alone or in combination w/ other meds to treat sx of parkinson’s
rasagiline
enhance activity of DA, NE, and 5-HT by inhibiting monoamine oxidase (MAO), thereby preventing degradation of the NTs
monoamine oxidase inhibitors (MAOIs)
drugs that act by blocking NT reuptake
serotonin/norepinephrine reuptake inhibitors (SNRIs)
norepinephrine/dopamine reuptake inhibitors (NDRIs)
tricyclic antidepressants (TCAs)
selective serotonin reuptake inhibitors (SSRIs)
how are neurotransmitters inactivated/reuptaken
how are the actions of neurotransmitters terminated
5-HT1 serotonin receptors
5-HT2 serotonin receptors